Tevogen Bio Inc. (TVGN)

NASDAQ: TVGN · Real-Time Price · USD

1.01

0.03 (3.23%)

At close: May 02, 2025, 3:59 PM

1.00

-1.73%

After-hours: May 02, 2025, 05:30 PM EDT

Tevogen Bio Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-13.73M	-67.33K	4.41M	-15.6M
Depreciation & Amortization	403.58K	n/a	230.82K	9.38K
Stock-Based Compensation	40.76M	n/a	4.58K	582.41
Other Working Capital	-1.69M	-34.33K	566.61K	-571.78K
Other Non-Cash Items	-39.43M	-2.21M	8.32M	10.98M
Deferred Income Tax	n/a	n/a	n/a	n/a
Change in Working Capital	-5.49K	897.62K	737.69K	-1.25M
Operating Cash Flow	-12M	-1.38M	-215.4K	-5.27M
Capital Expenditures	n/a	n/a	-479.04K	-109.73K
Cash Acquisitions	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	-351.9M
Sales Maturities Of Investments	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	342.92M	n/a	n/a
Investing Cash Flow	n/a	342.92M	-479.04	-109.73K
Debt Repayment	1M	1.32M	7.5K	12.5M
Common Stock Repurchased	n/a	-342.98M	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a
Other Financial Acitivies	229.33K	n/a	n/a	n/a
Financial Cash Flow	12.23M	-341.66M	7.5K	12.5M
Net Cash Flow	230.6K	-120.35K	-215.4K	7.12M
Free Cash Flow	-12M	-1.38M	-694.44K	-5.38M